Page 977 - Cardiac Nursing
P. 977

LWBK340-ind_p941-958.qxd  7/1/09  10:37 AM  Page 953 Aptara
         LWB K34 0-i nd_ p94 1-9 58. qxd   7 / 1 / 09   10 :37  AM   P a g e  95 3 A pta ra





                                                                                                             Index 953


                     MANAGEMENT OF     n             2ESTRICTIVE CARDIOMYOPATHY  2#-             3ICK SINUS SYNDROME     n        F
                     PATHOPHYSIOLOGY OF              2ESUSCITATION                     3IGNALING MOLECULE     T
                                                                                                         D
                                                                                                         D
                                                                                                             D

                                                                                                             D
                   0ULSELESS ARREST     F              INTEGRATED APPROACH TO FLUID     D  3INGLE CHAMBER PACING     Dn   D
                   0ULSELESS %LECTRICAL !CTIVITY  0%!        LACTATE AS OPTIMIZATION OF     n     3INGLE PHOTON EMISSION COMPUTED TOMOGRAPHY

                   0ULSE PRESSURE VARIATION     n     2EVERSE CHOLESTEROL TRANSPORT     n      30%#4           F

                   0ULSE WAVE $OPPLER          F     2HEUMATIC HEART DISEASE           3INUS ARREST     n        F

                                   F
                   0ULSUS ALTERNANS          F       2IBOSOMES    D                    3INUS ARRHYTHMIA
                                   F


                   0ULSUS BISFERIENS          F      2IGHT ATRIAL ENLARGEMENT     n     3INUS ARRHYTHMIA
                                F
                                F


                                       F
                                          F

                   0ULSUS PARADOXUS    F         F    F         F  2IGHT BUNDLE BRANCH BLOCK  2"""        3INUS BRADYCARDIA          n
                                       F

                                          F
                   0ULSUS PARVUS ET TARDUS           2IGHT VENTRICULAR ASSIST DEVICES  26!$        3INUS EXIT BLOCK
                   0UMP PERFORMANCE                  2IGHT VENTRICULAR END DIASTOLIC VOLUME INDEX  3INUS .ODE  3!
                   0URKINJE FIBERS                           26%$6)                    3INUS RHYTHM     F

                   0 7AVE  IN CARDIAC CYCLE          2IGHT VENTRICULAR ENLARGEMENT          n      3INUS TACHYCARDIA          F

                                                               D                       3IROLIMUS
                   Q                                 2IGHT VENTRICULAR OUTFL W TRACT  26/4        3IROLIMUS %LUTING 3TENT  3%3

                                  F
                                      F
                   123 AXIS     n        F    F    T  2ISK STRATIFICATION     D        3LEEP     n
                                      F

                                  F
                                                     2OSS PROCEDURE          F
                                                                                         AFTER CARDIAC SURGERY     n
                   123 COMPLEX          F            2OTATIONAL ATHERECTOMY              AGENTS TO PROMOTE     T

                   123 MORPHOLOGY     n              2OTH S SPOTS                        AROUSAL STATE OF
                   123 TACHYCARDIAS     F            2YANODINE RECEPTORS                 BEHAVIORAL ASSESSMENT OF

                   123 WIDTH     T                                                       BEHAVIOURS HABITS NONCONDUCTIVE TO     D
                   14 INTERVAL                                                           BENZODIAZEPINES     n
                     CONGENITAL                      S                                   CARDIOVASCULAR FUNCTION OF
                     DRUGS FOR     D                 3ALINE MICROBUBBLES     n           CEREBRAL BLOOD FL W IN     n

                     PROLONGATION OF          F      3ALVOS                              AND #/0$
                   14 SYNDROME     n                 3AN &RANCISCO CLUE     F            IN CORONARY CARE UNIT  ##5

                   1UANTITATIVE ANGIOGRAPHY     n     3APHENOUS VEIN BYPASS GRAFTS       IN CORONARY HEART DISEASE     n
                   1 WAVE          D                 3ARCOLEMMA                          CYCLES OF
                                                       DEFINITION OF                     DEFINITION
                   R                                   IONIC CURRENTS OF    n      T     AND DEPRESSION     n

                   2ADIAL ARTERY GRAFT BYPASS        3ARCOPLASM        F                 DEPRIVATION
                                                     3ECOND DEGREE !6 BLOCK
                   2ADIONUCLIDES                     3ECOND HEART  OF MUSCLE PUMP        DEVELOPMENTAL VARIATION OF PATTERNS OF
                     RISK OF                         3ECRETAGOGUES                       DISORDERS
                     STUDIES     n                   3ELECTIVE PERMEABILITY                BREATHING RELATED     D
                   2ADIONUCLIDE VENTRICULOGRAM  2.6'        3ELF EFFICAC                   CIRCADIAN RHYTHM IN     n
                                                                                                                D
                                                                                                                D
                   2APID EYE MOVEMENT  2%-             DEFINED                             INTERNATIONAL CLASSIFICATION O      Dn   D
                   2APID VENTRICULAR EJECTION          ENHANCEMENT                         OTHER     D

                   2ATE ADAPTIVE PACING              3ELF 2EPORT MEASURES  OF ADHERENCE     n     DISRUPTION          F
                              F

                              F
                   2 WAVE     F    F                          3EMILUNAR VALVES           DISTURBANCES  #4" FOR
                           F
                           F

                   2""" PATTERN          F           3ENSITIVITY  OF LABORATORY TEST          T     D  DISTURBANCES  MANAGEMENT

                                                                             T
                                                                             T
                   2EACTIVE HYPEREMIA                3EPTIC ENDARTERITIS                   COGNITIVE BEHAVIORAL THERAPY FOR
                   2ECURRENT PERICARDITIS            3EPTIC SHOCK     T                    COMPLEMENTARY AND ALTERNATIVE THERAPIES
                   2ED "LOOD #ELL  2"#  #OUNT     n     3ERUM AMYLOID !  3!!
                   2EDUCED VENTRICULAR EJECTION    n    3ERUM CONCENTRATIONS     n        T  EDUCATION AND HYGIENE
                   2EENTRY                           3ERUM ELECTROLYTES     n              LIGHT THERAPY     n

                     ANATOMIC          F               AFTER CARDIAC SURGERY               RELAXATION THERAPY AND IMAGERY
                     FUNCTIONAL                        ANION GAP     D     n               SLEEP RESTRICTION THERAPY
                                                                D
                                                                D
                   2EFLECTS RIGHT ATRIAL P ESSURE  2!0        CALCIUM     D                STIMULUS CONTROL
                                                               D
                                                               D
                   2EFRACTORY PERIODS    n             CARBON DIOXIDE                    AND $-     n
                   2EGIMEN RELATED FACTORS  OF ADHERENCE          T  CHLORIDE            EFFICIENC
                   2EGURGITANT MURMURS  3EE (OLOSYSTOLIC MURMURS  MAGNESIUM              ENDOCRINE FUNCTION
                   2ELAXATION EXERCISE     D           POTASSIUM                         ENVIRONMENTAL ASSESSMENT OF
                   2ELAXATION THERAPY                  SODIUM     n                      FUNCTION OF     n
                   2%- LATENCY                       3ERUM GLUTAMIC OXALOACETIC TRANSAMINASE  GOLD STANDARD
                   2%- SLEEP                                 3'/4        3EE ALSO !SPARTATE  IN HEALTH CARE PROVIDERS
                     NON 2%- SLEEP COMPARED TO  #/0$        AMINOTRANSFERASE  !34        AND (&
                     PHASIC                          3ERUM OSMOLALITY     D              HYGIENE
                                                                   D
                                                                   D
                     TONIC                           3EVERE HYPOPHOSPHATEMIA             IN HYPERTENSION
                                                                                                              D
                                                                                                              D
                   2ENAL FLUID E CRETION  HORMONES     T  CARDIAC EFFECTS OF             INTERNATIONAL CLASSIFICATION O      Dn   D
                   2ENIN ANGIOTENSIN ALDOSTERONE SYSTEM  2!!3    CAUSES OF          T    ISOLATED SYMPTOMS FOR DISORDERS OF

                             F
                               F                       VASCULAR EFFECTS OF               MOVEMENT DISORDERS     D
                             F
                     ACTIVATION OF     n             3EX CHROMOSOMES    D                .ONBENZODIAZEPINES TO PROMOTE
                     INHIBITORS OF     n        n     3HOCK                              NURSING CARE IN     n
                     INTERACTION WITH NATRIURETIC HORMONES      CARDIOGENIC SHOCK THERAPY     D  OBJECTIVE MEASUREMENT OF     n
                   2EPERFUSION STRATEGY     n          IN CARDIOVASCULAR ASSESSMENT       PHARMACOLOGIC AGENTS TO PROMOTE     T
                     DOOR TO BALLOON                   CLINICAL                          PHARMACOLOGICAL INTERVENTIONS
                     MEDICAL CONTACT TO NEEDLE TIME       CONGESTION     F                 ANTIDEPRESSANTS

                     PHARMACOLOGICAL     n             DEFINITION                          BENZODIAZEPINES     n
                   2ESISTANCE                          EXTRACARDIAC OBSTRUCTIVE            NONBENZODIAZEPINES
                   2ESPIRATORY PUMP    n               HEART FAILURE AND CARDIOGENIC       OVER THE COUNTER MEDICATIONS     n
                   2ESPIRATORY SINUS ARRHYTHMIA        REAL VS  PHANTOM                  PROMOTING INTERVENTIONS OF     n        T
                   2ESTENOSIS     n                  3HORT COUPLED 4D0  3EE 3HORT 14 3YNDROME  REGULATION OF  NORMAL
                     TREATMENT OPTIONS FOR IN STENT          3143                        RENAL FUNCTION IN
                   2ESTLESS ,EGS 3YNDROME  2,3      n                                    RESPIRATORY FUNCTION IN
                                                     3HORT 14 3YNDROME  3143
   972   973   974   975   976   977   978   979